|Brand Name :||ROSUVAS 5 Mg Tablet|
|Generic Name :||
Film coated tablet:
Rosuvastin calcium equivalent to 5 mg Rosuvastatin
|Type of Medicine :||Antihyperlipidemic, HMG-COA Reductase Inhibitor|
|Side Effects :||
Adverse effects are generally mild and transient. As with other HMG-CoA reductase inhibitors, the incidence of adverse drug reactions tends to be dose dependent.
Some adverse effect seen with this drug is as follow:
Myalgia, asthenia, diabetes mellitus, headache, dizziness, constipation, nausea, abdominal pains are common side effect of Rosuvastatin.
|Doses Form Available :||
|Dose Available :||
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Should not be used in any patient with an acute or serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (e.g. sepsis, hypotension, major surgery, trauma, severe metabolic, endocrine and electrolyte disorders; or uncontrolled seizures).
Should be used with caution in patients who consume excessive quantities of alcohol and/or have a history of liver disease. It is recommended that liver function tests be carried out prior to, and 3 months following, the initiation of treatment. Rosuvastatin should be discontinued or the dose reduced if the level of serum transaminases is greater than 3 times the upper limit of normal.
In patients with secondary hypercholesterolemia caused by hypothyroidism or nephrotic syndrome, the underlying disease should be treated prior to initiating therapy with Rosuvastin.
|Pharmaceuticals :||Ranbaxy Laboratories Limited|